Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica
Background: Surgery is an effective method for the management of renal hyperparathyroidism. Aim: To report the clinical presentation and results of surgical treatment of renal hyperparathyroidism. Material and Methods: Retrospective analysis of 58 patients aged 46 ± 11 years with secondary hyperpara...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2015
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000200006 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872015000200006 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720150002000062015-04-09Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónicaPulgar B,DahianaJara C,AquilesGonzález V,GilbertoGonzález D,Hernán Hyperparathyroidism, secondary Parathyroid hormone Surgery Background: Surgery is an effective method for the management of renal hyperparathyroidism. Aim: To report the clinical presentation and results of surgical treatment of renal hyperparathyroidism. Material and Methods: Retrospective analysis of 58 patients aged 46 ± 11 years with secondary hyperparathyroidism (HPT2) and 13 patients aged 53 ± 11 years with tertiary hyperparathyroidism (HPT3), operated at a clinical hospital. Results: In 55 cases (77.4%) the indications for surgery were complications of excess parathyroid hormone (PTH) and in 16 patients (22.6%) a failure of medical treatment. Total parathyroidectomy with intraoperative measurement of PTH (PTHop) plus a forearm parathyroid autograft was performed in 54 (93.1%) patients with HPT2 and in all patients with HPT3. PTHop decreased ≥ 75% in 51 patients (88%) with HPT2 and in 9 patients (69.2%) with HPT3, respectively. Cure of the disease was achieved in 52 (89.7%) and 11 (84.6%) patients with HPT2 and 3, respectively. Median follow-up was 41 months. Five (9.6%) patients with HPT2 and two patients (18.2%) with HPT3 had a recurrence of the disease. Conclusions: In patients with renal hyperparathyroidism, the primary indication for surgery was the presence of complications of PTH excess. A drop in PTHop ≥ 75% from baseline predicts healing in 98% and 100% of cases with secondary or tertiary HPT respectively. Surgery was a safe and effective treatment in both groups.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.143 n.2 20152015-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000200006es10.4067/S0034-98872015000200006 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Hyperparathyroidism, secondary Parathyroid hormone Surgery |
spellingShingle |
Hyperparathyroidism, secondary Parathyroid hormone Surgery Pulgar B,Dahiana Jara C,Aquiles González V,Gilberto González D,Hernán Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
description |
Background: Surgery is an effective method for the management of renal hyperparathyroidism. Aim: To report the clinical presentation and results of surgical treatment of renal hyperparathyroidism. Material and Methods: Retrospective analysis of 58 patients aged 46 ± 11 years with secondary hyperparathyroidism (HPT2) and 13 patients aged 53 ± 11 years with tertiary hyperparathyroidism (HPT3), operated at a clinical hospital. Results: In 55 cases (77.4%) the indications for surgery were complications of excess parathyroid hormone (PTH) and in 16 patients (22.6%) a failure of medical treatment. Total parathyroidectomy with intraoperative measurement of PTH (PTHop) plus a forearm parathyroid autograft was performed in 54 (93.1%) patients with HPT2 and in all patients with HPT3. PTHop decreased ≥ 75% in 51 patients (88%) with HPT2 and in 9 patients (69.2%) with HPT3, respectively. Cure of the disease was achieved in 52 (89.7%) and 11 (84.6%) patients with HPT2 and 3, respectively. Median follow-up was 41 months. Five (9.6%) patients with HPT2 and two patients (18.2%) with HPT3 had a recurrence of the disease. Conclusions: In patients with renal hyperparathyroidism, the primary indication for surgery was the presence of complications of PTH excess. A drop in PTHop ≥ 75% from baseline predicts healing in 98% and 100% of cases with secondary or tertiary HPT respectively. Surgery was a safe and effective treatment in both groups. |
author |
Pulgar B,Dahiana Jara C,Aquiles González V,Gilberto González D,Hernán |
author_facet |
Pulgar B,Dahiana Jara C,Aquiles González V,Gilberto González D,Hernán |
author_sort |
Pulgar B,Dahiana |
title |
Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
title_short |
Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
title_full |
Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
title_fullStr |
Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
title_full_unstemmed |
Tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
title_sort |
tratamiento quirúrgico del hiperparatiroidismo asociado a insuficiencia renal crónica |
publisher |
Sociedad Médica de Santiago |
publishDate |
2015 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000200006 |
work_keys_str_mv |
AT pulgarbdahiana tratamientoquirurgicodelhiperparatiroidismoasociadoainsuficienciarenalcronica AT jaracaquiles tratamientoquirurgicodelhiperparatiroidismoasociadoainsuficienciarenalcronica AT gonzalezvgilberto tratamientoquirurgicodelhiperparatiroidismoasociadoainsuficienciarenalcronica AT gonzalezdhernan tratamientoquirurgicodelhiperparatiroidismoasociadoainsuficienciarenalcronica |
_version_ |
1718436804232740864 |